Medical Developments International Limited
MDDVF
$0.3206
-$0.187-36.84%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.75% | 12.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.75% | 12.48% | |||
| Cost of Revenue | -2.75% | 13.89% | |||
| Gross Profit | -2.75% | 11.99% | |||
| SG&A Expenses | -2.75% | -13.52% | |||
| Depreciation & Amortization | -2.75% | -13.08% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.75% | -7.25% | |||
| Operating Income | -2.74% | 142.49% | |||
| Income Before Tax | -2.73% | 101.60% | |||
| Income Tax Expenses | -4.55% | -99.87% | |||
| Earnings from Continuing Operations | -2.75% | 101.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.75% | 101.03% | |||
| EBIT | -2.74% | 142.49% | |||
| EBITDA | -2.74% | 210.97% | |||
| EPS Basic | 0.00% | 100.78% | |||
| Normalized Basic EPS | 0.00% | 106.67% | |||
| EPS Diluted | 0.00% | 100.78% | |||
| Normalized Diluted EPS | 0.00% | 106.67% | |||
| Average Basic Shares Outstanding | 0.00% | 24.41% | |||
| Average Diluted Shares Outstanding | 0.00% | 30.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||